Analytical Data
-
Gene name
CATHL6
- Application
-
Alternative Names
CATHL6；BMAP27；Cathelicidin-6
-
Species
Bovine
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P54228
-
Expression Region
132-158aa
-
AA Sequence
GRFKRFRKKFKKLFKKLSPVIPLLHLG
-
Molecular Weight
3.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CATHL6, also known as Cathelicidin 6, is a member of the cathelicidin family of antimicrobial peptides, which play a crucial role in the innate immune system. These peptides are characterized by their ability to combat a broad spectrum of pathogens, including bacteria, viruses, and fungi. The study of CATHL6 is particularly significant due to its unique structural features and potential therapeutic applications, including its role in modulating inflammation and promoting wound healing. Research into CATHL6 has revealed its expression in various tissues and its involvement in the immune response, highlighting its importance in host defense mechanisms. Furthermore, due to the rising prevalence of antibiotic-resistant infections, CATHL6 and similar antimicrobial peptides are being explored as promising alternatives to traditional antibiotics. By investigating the biogenesis, mechanism of action, and potential clinical applications of CATHL6 recombinants, scientists aim to harness its antimicrobial properties to develop novel therapeutic strategies that could enhance immune function and improve outcomes in infectious diseases. Understanding the structure-function relationships underlying CATHL6 activity also holds potential for the design of engineered peptides with enhanced efficacy or specificity, paving the way for innovative treatments in the future. Overall, the ongoing research into CATHL6 recombinant protein presents a promising frontier in antimicrobial therapy and the broader field of immunology.
